RNA-Analyseverfahren

Patent europeic · EP2510114 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2510114
Numer da la dumonda
EP10788340
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-12-2010
Publitgà
17-10-2012
Concedì
20-04-2016
Stritgà
23-07-2026
Motiv
Taxa annuala betg pajada
Classas IPC
C12Q 1/68 (2006.01)
Prioritad
EP 09178923 11.12.2009
Dumonda PCT
PCT/EP2010/069382 10.12.2010
Publicaziun PCT
WO2011/070155 16.06.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-07-2026

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.07.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.07.2026

  2. 01-01-2025

    Next annual fee due on

    Next annual fee due on
    31.12.2024 → 31.12.2025

    Published in Swissreg on 01.01.2025

  3. 09-01-2024

    Midada

    Published in Swissreg on 09.01.2024

  4. 04-01-2023

    Midada

    Published in Swissreg on 04.01.2023

  5. 29-06-2016

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 29.06.2016

  6. 29-06-2016

    Adressa midada

    Owner
    Lexogen GmbH, Brunnerstrasse 69/Objekt 3, 1230 Vienna, Austria → Lexogen GmbH, Campus-Vienna-Biocenter 5, 1030 Wien, Austria

    Published in Swissreg on 29.06.2016

  7. 20-04-2016

    Concedì

    Published in Swissreg on 20.04.2016

Partidas

Inventur

SEITZ, Alexander

A-1140 Vienna, AT

PAUL, Lukas

A-1230 Vienna, AT

van MIN, Max Jan

NL-2497 ZJ Den Haag, NL

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.